Aktie 6541 TANVEX BIOPHARMA, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Tanvex BioPharma, Inc.

Aktien

6541

KYG8676P1037

6541

Schlusskurs Taiwan S.E.
Andere Börsenplätze
 00:00:00 03.05.2024 		% 5 Tage % 1. Jan.
45.6 TWD +0.11% Intraday Chart für Tanvex BioPharma, Inc. -5.00% -29.95%
14.03. Tanvex BioPharma, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI
06.02. Tanvex BioPharma, Inc. kündigt die Ernennung von James Williamson zum Rechnungswesenbeauftragten an CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Tanvex BioPharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Tanvex BioPharma, Inc. Announces the Appointment of James Williamson as Accounting Officer
Tanvex BioPharma, Inc. Announces the Appointment of Chen, Lin-Cheng as CEO
Tanvex Biologics Corporation announced that it expects to receive $5 million in funding from Tanvex BioPharma, Inc.
Tanvex BioPharma USA, Inc. announced that it expects to receive $50 million in funding from Tanvex BioPharma, Inc.
Tanvex BioPharma, Inc. Announces the Resignation of Ken Huang as Accounting Officer
Tanvex BioPharma, Inc. Announces Change of Chairman
Tanvex BioPharma, Inc. Announces Resignation of Yun Yen Chairperson and Director, Effective December 29, 2023
Tanvex BioPharma, Inc. Announces Change of Corporate Governance Officer
Tanvex BioPharma, Inc. Announces Resignation of Yun Yen as CEO, Effective December 29, 2023
Tanvex BioPharma, Inc. Announces Resignation of Yun Yen as Chairman/President, Effective December 29, 2023
Tanvex BioPharma, Inc. Announces the Resignation of Stacey Tsai as Acting Spokesperson and Corporate Governance Officer
Tanvex BioPharma, Inc. Appoints Wen Chung Yeh as Chief Financial Officer
Tanvex BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Tanvex BioPharma, Inc. Announces Management Changes
Tanvex BioPharma, Inc.(TWSE:6541) added to S&P Global BMI Index
Tanvex BioPharma, Inc.(TWSE:6541) added to Taiwan TAIEX Index
Tanvex BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Tanvex BioPharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Tanvex BioPharma, Inc.(TWSE:6541) dropped from Taiwan TAIEX Index
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 6541 Aktie
  4. Nachrichten Tanvex BioPharma, Inc.
  5. Andere Sprachen